Doxycycline for epistaxis in hereditary hemorrhagic telangiectasia: genotype-stratified outcomes
Blood Vessels, Thrombosis & Hemostasis
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Citation
Doxycycline for epistaxis in hereditary hemorrhagic telangiectasia: genotype-stratified outcomes. // Blood Vessels, Thrombosis & Hemostasis. – URL: https://www.sciencedirect.com/science/article/pii/S2950327226000586?dgcid=rss_sd_all
Doxycycline for epistaxis in hereditary hemorrhagic telangiectasia: genotype-stratified outcomes. Blood Vessels, Thrombosis & Hemostasis. https://www.sciencedirect.com/science/article/pii/S2950327226000586?dgcid=rss_sd_all
“Doxycycline for epistaxis in hereditary hemorrhagic telangiectasia: genotype-stratified outcomes.” Blood Vessels, Thrombosis & Hemostasis.
@article{article93441,
title = {Doxycycline for epistaxis in hereditary hemorrhagic telangiectasia: genotype-stratified outcomes},
journal = {Blood Vessels, Thrombosis \& Hemostasis},
url = {https://www.sciencedirect.com/science/article/pii/S2950327226000586?dgcid=rss_sd_all}
}